» Articles » PMID: 12043937

Glycohaemoglobin Measurement: Methodological Differences in Relation to Interference by Urea

Overview
Journal Acta Diabetol
Specialty Endocrinology
Date 2002 Jun 5
PMID 12043937
Citations 3
Authors
Affiliations
Soon will be listed here.
Abstract

The aim of this study was to investigate the agreement between a cation-exchange HPLC method and a boronate affinity method of measuring glycohaemoglobin (HbA1c), with particular reference to the effect of elevated urea concentration. HbA1c was measured by both methods in samples from 75 subjects who were classified as diabetic with normal (n=36) or abnormal (n=12) renal function, and non-diabetic with normal (n=8) or abnormal (n=19) renal function. Urea was found to cause a clinically significant interference in the HPLC method at a level > or =17.0 mmol/l. Each increase of 1 mmol/l urea in serum was associated with an absolute increase of 0.04% in the HbA1c value as measured by the HPLC method. The boronate affinity method for HbA1c did not appear to be affected by elevated urea concentration. There was significant correlation (r=0.97, p<0.001) between HbA1c results obtained by the two methods, however, results obtained by the boronate affinity method were generally lower. The discrepancy between results obtained by the two methods was particularly marked in uraemic samples from diabetic subjects, as the HPLC/boronate affinity difference increased as the HbA1c increased and also as the urea concentration increased. Results indicate that blood from diabetic patients with renal failure may give erroneously high HbA1c values by HPLC. Results also highlight the importance of choosing appropriate clinical samples and statistical techniques when evaluating or comparing test methods.

Citing Articles

Continuous glucose monitoring in people with diabetes and end-stage kidney disease-review of association studies and Evidence-Based discussion.

Jakubowska Z, Malyszko J J Nephrol. 2023; 37(2):267-279.

PMID: 37989976 PMC: 11043101. DOI: 10.1007/s40620-023-01802-w.


Continuous glucose monitoring in patients with type 2 diabetes on hemodialysis.

Gallieni M, De Salvo C, Lunati M, Rossi A, DAddio F, Pastore I Acta Diabetol. 2021; 58(8):975-981.

PMID: 33743082 PMC: 8272699. DOI: 10.1007/s00592-021-01699-6.


Assessing glycemic control in maintenance hemodialysis patients with type 2 diabetes.

Kazempour-Ardebili S, Lecamwasam V, Dassanyake T, Frankel A, Tam F, Dornhorst A Diabetes Care. 2009; 32(7):1137-42.

PMID: 19196889 PMC: 2699727. DOI: 10.2337/dc08-1688.